Рыночные новости
Заголовки по акциям и крипте из Alpaca. Храним 7 дней. Всего: 9855.
-
Estée Lauder CEO Declares 'Best Is Yet To Come' With Ambitious 2030 Growth TargetsEstée Lauder (EL) stock rises after unveiling its 2030 targets and Beauty Reimagined plan following a strong Q1 earnings beat.
-
Block To Rally Around 54%? Here Are 10 Top Analyst Forecasts For WednesdayAnalysts raised targets for FRSH, EW, ATRC, SUPN and DUOL; cut targets for FLG and AMD. EW was upgraded, while FLG was downgraded.
-
Riot sells 20,264 Bitcoin for $1.5B to fund data center expansionRiot's strategic leases could enhance long-term growth, but managing debt and timely project execution are crucial for sustained success. The post Riot sells 20,264 Bitcoin for $1.5B to fund data center expansion appeared first on Crypto Briefing .
-
The New York Times Company Announces Third-Quarter 2026 Financial ResultsThe New York Times Company scheduled the release of its third-quarter 2026 financial results for November 4, 2026.
-
Circle beats earnings expectations on strong revenue, but cuts 5% of its workforceCircle’s net income for continuing operations of $226 million grew 5% year-over-year to $226 million in the third quarter.
-
Glaukos Insider Executes Significant Share SaleA Glaukos Corporation insider has sold shares valued at approximately $10.6 million, as disclosed in a recent SEC filing.
-
BTIG and Barclays Downgrade Driven BrandsAnalysts at BTIG and Barclays downgraded Driven Brands Holdings Inc. on November 4, 2026, following recent company disclosures regarding financial restatements and lowered earnings guidance.
-
Analyst Adjusts Price Target for BioMarin Pharmaceutical Inc.An analyst has updated the 12-month price target for BioMarin Pharmaceutical Inc. to $90.85.
-
Stella-Jones Reports Third Quarter 2026 Financial ResultsStella-Jones Inc. announced its financial results for the third quarter ended September 30, 2026, reporting sales of $979 million and adjusted EBITDA of $159 million.
-
Stella-Jones Announces Normal Course Issuer Bid and Quarterly DividendStella-Jones Inc. received approval for a new normal course issuer bid to repurchase up to 1.5 million common shares and declared a quarterly dividend of $0.34 per share.
-
BioCryst Pharmaceuticals Reports Third Quarter 2026 Financial ResultsBioCryst Pharmaceuticals, Inc. announced its financial results for the third quarter ended September 30, 2026, highlighting continued growth of its ORLADEYO therapy.
-
Truist Securities Adjusts Price Target on Graphic PackagingTruist Securities has updated its price target for Graphic Packaging Holding Company to $10 from $9, while maintaining a "Hold" rating.
-
Graphic Packaging Launches Boardio™ Paperboard Packaging for Nutraceutical BrandsGraphic Packaging International, LLC has introduced its Boardio™ paperboard packaging solution, designed to help nutraceutical brands enhance on-shelf presence and sustainability.
-
Enerpac Tool Group Hosts 2026 Investor Day and Unveils Propel StrategyEnerpac Tool Group held its 2026 Investor Day at the New York Stock Exchange, where leadership introduced the new 'Propel' strategy and established fiscal 2030 financial targets.
-
Barclays Maintains Hold Rating and $16 Price Target for The Chemours CompanyBarclays has reaffirmed its 'Hold' rating and $16 price target for The Chemours Company.
-
Centerra Gold Inc. Exercises Equity Participation Rights in Kenorland Minerals Ltd.Centerra Gold Inc. has notified Kenorland Minerals Ltd. of its intent to exercise equity participation rights to maintain its 9.9% interest in the company.
-
Maple Leaf Foods Reports Third Quarter 2026 Financial ResultsMaple Leaf Foods Inc. announced its financial results for the third quarter ended September 30, 2026, reporting growth in sales and adjusted EBITDA.
-
Addus HomeCare Corporation Analyst Price Target IncreasedAnalysts have raised the average 12-month price target for Addus HomeCare Corporation to $134.92.
-
Northwest Bancshares to Go Ex-Dividend on November 5th, 2026Northwest Bancshares, Inc. is scheduled to go ex-dividend on November 5, 2026, with a dividend payment of $0.20 per share.
-
Truist Securities Adjusts Price Target on Boise Cascade to $86 From $97, Keeps Buy RatingTruist Securities has revised its price target for Boise Cascade Company, lowering it from $97 to $86 while maintaining a Buy rating.